Encompass Health (EHC) files Form 144 for 8,906 RSU-based shares

Rhea-AI Filing Summary

Encompass Health Corporation filed a notice of proposed sale of 8,906 shares of common stock through UBS Financial Services Inc. The shares relate to multiple RSU vesting events in 2025, and the filing lists an aggregate market value of $1,121,700.88 for these securities as of the filing details. The shares are listed on the NYSE and the proposed sale date is August 10, 2026.

Key Figures

Shares proposed for sale: 8,906 shares Aggregate market value: $1,121,700.88 Largest RSU vesting lot: 3,864 shares +1 more

4 metrics

Shares proposed for sale 8,906 shares Common stock listed with UBS Financial Services Inc for proposed sale

Aggregate market value $1,121,700.88 Value associated with the 8,906 common shares in the notice

Largest RSU vesting lot 3,864 shares Single RSU Vesting tranche of Encompass Health common stock

Proposed sale date 08/10/2026 Date listed for sale of all RSU-related share lots

Key Terms

Form 144, RSU Vesting, Common Stock

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vesting financial

"Common Stock | 01/01/2025 | RSU Vesting | Encompass Health Corporation"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

Common Stock financial

"Common Stock | UBS Financial Services Inc 1000 Harbor Blvd"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 05:21 PM Accepted by SEC EDGAR 08/10/2026 - 05:20 PM Learn about SEC filing dates

FAQ

What stock sale is Encompass Health (EHC) registering in this Form 144?

Encompass Health is registering a proposed sale of 8,906 shares of common stock. The notice identifies UBS Financial Services Inc as the broker and lists the shares as NYSE-listed common stock.

What is the aggregate value of Encompass Health (EHC) shares in this Form 144?

The filing lists an aggregate market value of $1,121,700.88 for the 8,906 common shares. This figure reflects the value used for the Form 144 notice, not necessarily the final sale proceeds.

When are the Encompass Health (EHC) shares proposed to be sold under this Form 144?

The proposed sale date for the Encompass Health common stock is August 10, 2026. This date applies to all the RSU-related share lots listed in the Form 144 notice.

What is the source of the Encompass Health (EHC) shares in this Form 144?

The shares arise from several RSU Vesting events in 2025. Individual vesting dates include 01/01/2025, 02/23/2025, 02/25/2025, and 02/28/2025 across multiple lots.

How many Encompass Health (EHC) shares were tied to each RSU vesting lot?

The Form 144 lists RSU vesting lots of 3,335, 3,864, 548, 638, and 521 shares. Together these lots total 8,906 shares of Encompass Health common stock proposed for sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	8906	1121700.88	98653384	08/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/01/2025	RSU Vesting	Encompass Health Corporation			3335	08/10/2026	N/A
Common Stock	01/01/2025	RSU Vesting	Encompass Health Corporation			3864	08/10/2026	N/A
Common Stock	02/23/2025	RSU Vesting	Encompass Health Corporation			548	08/10/2026	N/A
Common Stock	02/25/2025	RSU Vesting	Encompass Health Corporation			638	08/10/2026	N/A
Common Stock	02/28/2025	RSU Vesting	Encompass Health Corporation			521	08/10/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)